Hedges Asset Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$317K Buy
+3,500
New +$293K 0.21% 91
2025
Q4
$332K Buy
+3,900
New +$320K 0.23% 87
2025
Q3
Sell
-3,900
Closed -$305K 105
2025
Q2
$305K Hold
3,900
0.25% 86
2025
Q1
$283K Hold
3,900
0.19% 95
2024
Q4
$289K Hold
3,900
0.19% 94
2024
Q3
$257K Hold
3,900
0.17% 99
2024
Q2
$360K Hold
3,900
0.26% 84
2024
Q1
$373K Buy
+3,900
New +$328K 0.26% 79
2023
Q4
Sell
-3,900
Closed -$270K 108
2023
Q3
$270K Hold
3,900
0.24% 86
2023
Q2
$368K Hold
3,900
0.31% 78
2023
Q1
$323K Hold
3,900
0.27% 81
2022
Q4
$291K Hold
3,900
0.26% 82
2022
Q3
$322K Hold
3,900
0.32% 75
2022
Q2
$373K Hold
3,900
0.35% 74
2022
Q1
$459K Hold
3,900
0.36% 73
2021
Q4
$505K Buy
+3,900
New +$455K 0.39% 72

Other funds holding EW

Hedges Asset Management's EW Position: Q2 2026 in Review

Hedges Asset Management opened a new position in Edwards Lifesciences (EW) in Q2 2026: 3,500 shares worth $317K. The stake represents 0.21% of the portfolio and ranks #91 among its holdings. This is a return to the name: Hedges Asset Management previously reported a position in EW as recently as Q4 2025.

Hedges Asset Management first reported a position in EW in Q4 2021 and has held it in 16 quarters since. The position peaked at $505K in Q4 2021. 1,330 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Hedges Asset Management held 3,500 shares of Edwards Lifesciences worth $317K as of Q2 2026.
  • Edwards Lifesciences was a new Hedges Asset Management position in Q2 2026.
  • Edwards Lifesciences made up 0.21% of Hedges Asset Management's portfolio in Q2 2026, its #91 holding.
  • Hedges Asset Management first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 16 quarters since.
  • Hedges Asset Management's Edwards Lifesciences position peaked at $505K in Q4 2021.
  • 1,330 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Hedges Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.